7 alpha-hydroxy-4-cholesten-3-one has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DePaoli, AM; Elliott, M; Ko, B; Learned, RM; Lindhout, DA; Ling, L; Luo, J; Phung, V; Tian, H; To, C; Zhou, M | 1 |
| Abrahamsson, A; Angelin, B; Björkhem, I; Eggertsen, G; Einarsson, C; Gustafsson, U; Ingelman-Sundberg, M; Johansson, I; Krapivner, S; Muhrbeck, O; Persson, I; van't Hooft, FM | 1 |
1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Liver Neoplasms
| Article | Year |
|---|---|
A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Topics: Adult; Animals; Australia; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Double-Blind Method; Down-Regulation; Fibroblast Growth Factors; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Variation; Healthy Volunteers; Humans; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Recombinant Proteins; Risk Assessment; RNA, Messenger; Young Adult | 2014 |
1 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Liver Neoplasms
| Article | Year |
|---|---|
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Cholesterol, LDL; Genetic Testing; Genetic Variation; Haplotypes; Humans; Liver Neoplasms; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Promoter Regions, Genetic; Transcription, Genetic | 2005 |